Objectives To describe the incidences of injuries and illnesses sustained during the XXIV Winter Olympic Games, hosted by Beijing in 2022. Methods We recorded the daily number of injuries and illnesses in athletes and nonathletes in the polyclinic and medical venues documented by the Beijing 2022 medical staff. Results In total, 35,537 athletes and nonathletes were evaluated for injuries and illnesses. The Beijing 2022 medical staff reported 725 injuries and 1119 illnesses comprising 24 injuries and 31 illnesses per 1000 athletes and nonathletes during the Winter Olympic Games. Altogether, 2.4% of the athletes and nonathletes incurred at least one injury and 3.1% had at least one illness. The injury incidence was highest in athletes (14.4%), team officials (8.8%), staff (2.1%), and volunteers (2.1%), and lowest in national and international technical officials (1.5%) and stakeholders (0.3%). The highest incidences of illness were recorded in team officials (7.5%), volunteers (4.8%), and athletes (4.6%). Seventeen percent of the illnesses and injuries affected the oral structures, 15.4% affected the gastrointestinal system, and 10.5% affected the respiratory system. Conclusion The injury morbidity rate of athletes was 14.4%, and the illness morbidity rate was 4.6%. For nonathletes, the injury morbidity rate was 2.0%, and the illness morbidity rate was 3.1%. The incidences of injuries and illnesses varied substantially among the different categories of participants. Analyses of the injury mechanisms and illness causes in athletes and nonathletes during the Winter Olympic Games are essential to devise better injury and illness prevention strategies.

The authors have declared no competing interest.

The China Natural Youth Fund (31900961), Innovation & Transfer Fund of Peking University Third Hospital (HDCXZHKC2021213), Key Clinical Projects of Peking University Third Hospital (BYSYZD2019024), and The 2019 National Key Research and Development Program for Science and Technology Winter Olympics of China (2019YFF0302305) funded the data collection in this study.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was reviewed and approved by the Peking University Third Hospital Medical Science Research Ethics Committee (M2022428).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

All data relevant to the study are included in the article.